Home  |  Contact

Cellosaurus Tm87-16 (CVCL_8001)

[Text version]

Cell line name Tm87-16
Synonyms TM87-16; TM 87-16; TM87; TM
Accession CVCL_8001
Resource Identification Initiative To cite this cell line use: Tm87-16 (RRID:CVCL_8001)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Doubling time: 45 hours (PubMed=1747867).
Omics: Deep exome analysis.
Sequence variations Gene deletion; SMARCB1; Zygosity=Homozygous (PubMed=10602515; PubMed=11921280).
Disease Extrarenal rhabdoid tumor (NCIt: C6586)
Rhabdoid tumor (ORDO: Orphanet_69077)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 1Y9M
Category Cancer cell line
Publications

PubMed=1747867; DOI=10.1016/0165-4608(91)90359-3
Karnes P.S., Tran T.N., Cui M.Y., Bogenmann E., Shimada H., Ying K.L.
Establishment of a rhabdoid tumor cell line with a specific chromosomal abnormality, 46,XY,t(11;22)(p15.5;q11.23).
Cancer Genet. Cytogenet. 56:31-38(1991)

PubMed=8385567; DOI=10.1002/1097-0142(19930501)71:9<2862::AID-CNCR2820710930>3.0.CO;2-D
Ota S., Crabbe D.C.G., Tran T.N., Triche T.J., Shimada H.
Malignant rhabdoid tumor. A study with two established cell lines.
Cancer 71:2862-2872(1993)

PubMed=9920784; DOI=10.1006/bbrc.1998.9968
Mori T., Fukuda Y., Kuroda H., Matsumura T., Ota S., Sugimoto T., Nakamura Y., Inazawa J.
Cloning and characterization of a novel Rab-family gene, Rab36, within the region at 22q11.2 that is homozygously deleted in malignant rhabdoid tumors.
Biochem. Biophys. Res. Commun. 254:594-600(1999)

PubMed=10602515; DOI=10.1038/sj.onc.1203168
DeCristofaro M.F., Betz B.L., Wang W., Weissman B.E.
Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.
Oncogene 18:7559-7565(1999)

PubMed=11557780; DOI=10.1038/modpathol.3880401
Itakura E., Tamiya S., Morita K., Shiratsuchi H., Kinoshita Y., Oshiro Y., Oda Y., Ohta S., Furue M., Tsuneyoshi M.
Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence.
Mod. Pathol. 14:854-861(2001)

PubMed=11921280; DOI=10.1002/gcc.10052
Uno K., Takita J., Yokomori K., Tanaka Y., Ohta S., Shimada H., Gilles F.H., Sugita K., Abe S., Sako M., Hashizume K., Hayashi Y.
Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
Genes Chromosomes Cancer 34:33-41(2002)

PubMed=12210830; DOI=10.1002/jnr.10330
Yoshida S., Narita T., Taga T., Ohta S., Takeuchi Y.
Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex.
J. Neurosci. Res. 69:642-652(2002)

PubMed=16557275; DOI=10.1038/modpathol.3800599
Izumi T., Oda Y., Hasegawa T., Nakanishi Y., Iwasaki H., Sonobe H., Goto H., Kusakabe H., Takahira T., Kobayashi C., Kawaguchi K.-I., Saito T., Yamamoto H., Tamiya S., Iwamoto Y., Tsuneyoshi M.
Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Mod. Pathol. 19:820-831(2006)

PubMed=24418192; DOI=10.1111/cas.12352
Takita J., Chen Y., Kato M., Ohki K., Sato Y., Ohta S., Sugita K., Nishimura R., Hoshino N., Seki M., Sanada M., Oka A., Hayashi Y., Ogawa S.
Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.
Cancer Sci. 105:258-264(2014)

PubMed=31068700; DOI=10.1038/s41586-019-1186-3
Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature 569:503-508(2019)

Cross-references
Cell line databases/resources CCLE; TM87_SOFT_TISSUE
DepMap; ACH-000172
TOKU-E; 4151
Biological sample resources BioSample; SAMN10989624
Chemistry resources PharmacoDB; TM8716_1599_2019
Other Wikidata; Q54972667
Polymorphism and mutation databases Cosmic; 801769
Cosmic; 802049
Cosmic; 802247
Cosmic; 1063887
Cosmic; 2144782
Entry history
Entry creation04-Apr-2012
Last entry update12-Jan-2021
Version number16